» Authors » Leif Bostad

Leif Bostad

Explore the profile of Leif Bostad including associated specialties, affiliations and a list of published articles. Areas
Snapshot
Articles 60
Citations 875
Followers 0
Related Specialties
Top 10 Co-Authors
Published In
Affiliations
Soon will be listed here.
Recent Articles
1.
Nordanger I, Beisland C, Thorkelsen T, Honore A, Juliebo-Jones P, Bostad L, et al.
Clin Genitourin Cancer . 2024 Jun; 22(5):102127. PMID: 38918085
Introduction: Penile squamous cell carcinoma (PSCC) can develop from human papillomavirus (HPV) infection. This study investigates if the prognostic value of the TNM stage groups or the components tumor stage...
2.
Haaskjold Y, Lura N, Bjorneklett R, Bostad L, Knoop T, Bostad L
Clin Kidney J . 2023 Dec; 16(12):2514-2522. PMID: 38046027
Background: The establishment of the Oxford classification and newly developed prediction models have improved the prognostic information for immunoglobulin A nephropathy (IgAN). Considering new treatment options, optimizing prognostic information and...
3.
Moen C, Falkenthal T, Thorkelsen T, Hopland A, Rio O, Honore A, et al.
Eur Urol Oncol . 2023 Nov; 7(4):778-785. PMID: 37949729
Background: Human papillomavirus (HPV) infection is a risk factor for the development of penile squamous cell carcinoma (PSCC). It remains inconclusive whether HPV-related PSCC has a different prognosis from non-HPV-related...
4.
Strauss P, Rivedal M, Scherer A, Eikrem O, Nakken S, Beisland C, et al.
Sci Rep . 2022 Aug; 12(1):13503. PMID: 35931808
Clear cell renal cell carcinoma (ccRCC) is the most common renal cancer. Identification of ccRCC likely to progress, despite an apparent low risk at the time of surgery, represents a...
5.
Haaskjold Y, Lura N, Bjorneklett R, Bostad L, Bostad L, Knoop T
Nephrol Dial Transplant . 2022 Jul; 38(5):1183-1191. PMID: 35904322
Background: Recently, two immunoglobulin A (IgA) nephropathy-prediction tools were developed that combine clinical and histopathologic parameters. The International IgAN Prediction Tool predicts the risk for 50% declines in the estimated...
6.
Haaskjold Y, Bjorneklett R, Bostad L, Bostad L, Lura N, Knoop T
BMC Nephrol . 2022 Jan; 23(1):26. PMID: 35016634
Background: The Oxford classification/MEST score is an established histopathologic scoring system for patients with IgA nephropathy (IgAN). The objective of this study was to derive a prognostic model for IgAN...
7.
Nakken S, Eikrem O, Marti H, Beisland C, Bostad L, Scherer A, et al.
Cancer Cell Int . 2021 Dec; 21(1):690. PMID: 34930263
Background: Clear cell renal cell carcinoma (ccRCC) is the most common subtype of renal cancer and one of the most common cancers. While survival for localized ccRCC is good, the...
8.
Gudbrandsdottir G, Aarstad H, Hjelle K, Forde K, Reisaeter L, Bostad L, et al.
Cytokine . 2021 Aug; 148:155666. PMID: 34389231
No abstract available.
9.
Gudbrandsdottir G, Aarstad H, Hjelle K, Forde K, Reisaeter L, Bostad L, et al.
Cytokine . 2021 May; 144:155586. PMID: 34058568
Purpose: The main aim was to map serum levels of IL-1/IL-6 family cytokines and relevant receptors from serum samples taken across treatment in patients with Renal Cell Carcinoma (RCC). Additionally,...
10.
Aarstad H, Gudbrandsdottir G, Hjelle K, Bostad L, Bruserud O, Anderson Tvedt T, et al.
Cancers (Basel) . 2020 Jul; 12(7). PMID: 32707675
High serum levels of the acute phase protein C-reactive protein (CRP) are associated with an adverse prognosis in renal cancer. The acute phase reaction is cytokine-driven and includes a wide...